Toolkit/RAST inhibition

RAST inhibition

Assay Method·Research·Since 2000

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Using RAST and RAST inhibition, Barnett et al. ( 1) showed that peanut-allergic individuals had extensive IgE binding to other legumes, including soy.

Usefulness & Problems

Why this is useful

RAST inhibition is described as an in vitro immunologic approach used to show extensive IgE binding to other legumes in peanut-allergic individuals. In this review it functions as evidence for antigenic similarity rather than definitive clinical diagnosis.; measuring IgE binding cross-reactivity among legumes; probing shared antigenicity between peanut and soy

Source:

RAST inhibition is described as an in vitro immunologic approach used to show extensive IgE binding to other legumes in peanut-allergic individuals. In this review it functions as evidence for antigenic similarity rather than definitive clinical diagnosis.

Source:

measuring IgE binding cross-reactivity among legumes

Source:

probing shared antigenicity between peanut and soy

Problem solved

It helps identify whether antibodies recognize related legume proteins such as soy.; detects serologic cross-reactivity that may underlie multiple positive allergy tests

Source:

It helps identify whether antibodies recognize related legume proteins such as soy.

Source:

detects serologic cross-reactivity that may underlie multiple positive allergy tests

Problem links

detects serologic cross-reactivity that may underlie multiple positive allergy tests

Literature

It helps identify whether antibodies recognize related legume proteins such as soy.

Source:

It helps identify whether antibodies recognize related legume proteins such as soy.

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Target processes

No target processes tagged yet.

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor

The method requires allergic patient sera and assay reagents for measuring IgE binding and inhibition.; requires patient sera and immunologic assay infrastructure

The review explicitly indicates that such in vitro findings alone do not establish clinically important cross-reactivity.; the review indicates that in vitro cross-reactivity did not necessarily predict clinical coreactivity

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1review summarysupports2000Source 1needs review

Elimination of all legumes in individuals with clinical reactions to one legume is generally unwarranted despite frequent multiple positive legume tests.

Claim 2review summarysupports2000Source 1needs review

Epitope analysis suggests that linear IgE-binding epitopes are prominent in major peanut allergens and that some single amino-acid substitutions can reduce IgE binding, implying therapeutic potential.

Claim 3review summarysupports2000Source 1needs review

Molecular studies indicate that peanut and soy contain both homologous and unique allergenic proteins, helping explain why serologic cross-reactivity does not always produce clinical coallergy.

Claim 4review summarysupports2000Source 1needs review

Serologic or skin-test cross-reactivity between peanut and soy is common, but clinically important peanut-soy coallergy is uncommon.

clinical soy reactivity in peanut allergic children 3%coallergy rate atopic dermatitis cohort 1 0.8%coallergy rate atopic dermatitis cohort 2 1.8%soy reactivity among severe peanut allergy cases 6.5%

Approval Evidence

1 source1 linked approval claimfirst-pass slug rast-inhibition
Using RAST and RAST inhibition, Barnett et al. ( 1) showed that peanut-allergic individuals had extensive IgE binding to other legumes, including soy.

Source:

review summarysupports

Serologic or skin-test cross-reactivity between peanut and soy is common, but clinically important peanut-soy coallergy is uncommon.

Source:

Comparisons

Source-stated alternatives

The review contrasts these in vitro studies with oral food challenges and clinical observation.

Source:

The review contrasts these in vitro studies with oral food challenges and clinical observation.

Source-backed strengths

used in the review as evidence for extensive IgE binding to other legumes including soy

Source:

used in the review as evidence for extensive IgE binding to other legumes including soy

Compared with Oral food challenge

The review contrasts these in vitro studies with oral food challenges and clinical observation.

Shared frame: source-stated alternative in extracted literature

Strengths here: used in the review as evidence for extensive IgE binding to other legumes including soy.

Relative tradeoffs: the review indicates that in vitro cross-reactivity did not necessarily predict clinical coreactivity.

Source:

The review contrasts these in vitro studies with oral food challenges and clinical observation.

Ranked Citations

  1. 1.
    StructuralSource 1Allergy2000Claim 1Claim 2Claim 3

    Seeded from load plan for claim cl4. Extracted from this source document.